Platelet Rich Fibrin+1% Alendronate in Treatment of Chronic Periodontitis
Efficacy Of Platelet Rich Fibrin With 1% Alendronate For Treatment Of Intrabony Defects In Chronic Periodontitis: A Randomized Controlled Clinical Trial
1 other identifier
interventional
90
1 country
1
Brief Summary
The present study is designed to evaluate the combined efficacy of Platelet Rich Fibrin (PRF) and 1% Alendronate (ALN) with open flap debridement (OFD) in treatment of intrabony defects in chronic periodontitis patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Oct 2014
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2015
CompletedFirst Submitted
Initial submission to the registry
August 4, 2015
CompletedFirst Posted
Study publicly available on registry
August 7, 2015
CompletedAugust 7, 2015
August 1, 2015
8 months
August 4, 2015
August 6, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
defect depth reduction (%)
assessed in percentage
Change from baseline to 9 months
Secondary Outcomes (5)
probing depth (mm)
Change from baseline to 9 months
clinical attachment level (mm)
Change from baseline to 9 months
gingival marginal level (mm)
Change from baseline to 9 months
modified sulcus bleeding index
Change from baseline to 9 months
plaque index
Change from baseline to 9 months
Study Arms (3)
Group 1
ACTIVE COMPARATORScaling and Root Planing (SRP) with Open flap debridement (OFD) alone for treating periodontal defect
Group 2
ACTIVE COMPARATORSRP with Open flap debridement (OFD) with Platelet rich fibrin (PRF) for treating periodontal defect
Group 3
ACTIVE COMPARATORSRP with Open flap debridement (OFD) with Platelet rich fibrin (PRF)+1% Alendronate for treating periodontal defect
Interventions
Oral prophylaxis followed by Open flap debridement (OFD) with Platelet rich fibrin (PRF) placement into the bone defect
Oral prophylaxis followed by Open flap debridement (OFD) with Platelet rich fibrin (PRF)+1% Alendronate placement into the bone defect
Eligibility Criteria
You may qualify if:
- Presence of 3-wall IBD ≥3 mm deep (distance between alveolar crest and base of the defect on an Intra-oral Periapical Radiograph \[IOPA\]) along with an interproximal probing depth (PD) ≥5 mm after phase I therapy (scaling and root planing\[SRP\]) in asymptomatic teeth.
You may not qualify if:
- Aggressive Periodontitis patients;
- Systemic conditions known to affect the periodontal status;
- medications known to affect the outcomes of periodontal therapy;
- Hematological disorders and insufficient platelet count (\<200,000/mm3);
- Pregnancy/lactation;
- Smoking and tobacco use in any form
- Immunocompromised individuals.
- Those having unacceptable oral hygiene (plaque index27 \[PI\] \>1.5) after reevaluation of Phase I therapy .
- Teeth with furcation involvement, non-vital teeth, carious teeth indicated for restorations and mobility of at least grade II were also excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Government Dental College and Research Institute
Bangalore, Karnataka, 560002, India
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. A R Pradeep, Professor, Government Dental College and Research Institute, Bangalore
Study Record Dates
First Submitted
August 4, 2015
First Posted
August 7, 2015
Study Start
October 1, 2014
Primary Completion
June 1, 2015
Study Completion
June 1, 2015
Last Updated
August 7, 2015
Record last verified: 2015-08